Skip to search formSkip to main contentSkip to account menu

GSK 1018921

Known as: GSK-1018921, GSK1018921 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The current interest in developing Glycine transporter Type 1 (GlyT‐1) inhibitors, for diseases such as schizophrenia, has led to… 
2011
2011
The pharmacokinetics (PK), safety, and tolerability of GSK1018921, a glycine transporter 1 (GlyT–1) inhibitor, were assessed in… 
2010
2010
In 2008 the Food and Drug Administration (FDA) modified its standard for evaluating toxicity of drug metabolites defining…